Singapore markets close in 7 hours 59 minutes

Straits Times Index
3,208.86
-8.55(-0.27%)
Nikkei
31,415.30
-344.58(-1.08%)
Hang Seng
17,809.66
+436.66(+2.51%)
FTSE 100
7,510.72
-97.36(-1.28%)
Bitcoin USD
27,418.81
-517.34(-1.85%)
CMC Crypto 200
587.04
-16.50(-2.73%)

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

103.31

+0.02

(+0.02%)

At close: 04:00PM EDT

103.51

+0.20

(+0.19%)

After hours:

07:59PM EDT

Trade prices are not sourced from all markets

All

Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way.
Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.
Motley Fool
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
Once a relatively unknown biotech company, Moderna (NASDAQ: MRNA) became a household name when it became one of the first companies to offer a vaccine for the COVID-19 virus. At its peak, Moderna saw quarterly revenue of $7 billion as it sold vaccines to the world. Its stock price followed suit, reaching an all-time high of $484 in mid-2021.